Purchase Order 75N98026P01746
- Not listed
- This is a firm-fixed-price purchase order award to Alamar Biosciences, Inc. by the National Institute on Aging (NIA), a civilian agency, for $247,000.00. The contract is for providing proteomic analysis services, including the NULISAseq CNS Disease Panel 120 assay, next-generation sequencing, and bioinformatic support for 1,118 plasma samples. The purpose is to identify biomarkers that can be used to classify and stage Alzheimer's disease. This award is not associated with a set-aside and is the...
- <p>The National Institute on Aging, a civilian federal agency, awarded a firm-fixed-price purchase order contract to Alamar Biosciences, Inc. to provide the ARGO HT INSTRUMENT AND NULISASEQ CNS DISEASE PANEL. The $2,751,760.00 contract has a period of performance through September 17, 2025. This contract does not have a set-aside designation. Alamar Biosciences, Inc. is a for-profit manufacturer of goods.</p>
- This is a firm-fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency, to Alamar Biosciences, Inc. for the ALAMAR NULISASEQ INFLAMMATION PANEL 250 REAGENTS. The contract has a ceiling value of $324,000.00 and a period of performance through July 7, 2025. Alamar Biosciences, Inc. is a for-profit manufacturer of specialized biomedical research tools and services, with a focus on diagnostic technologies for central nervous system disorders like...
- The National Institute on Aging (NIA) has awarded a $25,000 firm fixed-price purchase order to Alamar Biosciences, Inc. for preventive maintenance and repair services on Argo System Proteomics Equipment. The contract, awarded on February 13, 2026, with an ultimate completion date of February 12, 2027, will be performed in Baltimore, Maryland. This is an open market procurement with no set-aside designation, allowing Alamar Biosciences to compete based on its specialized technical capabilities in...
- The National Institute on Aging awarded a purchase order to Banner Health (operating as Banner Research Institute) for $6,996,600 on August 1, 2026, for NULISA proteomic liquid biopsy testing services to identify biomarkers associated with Alzheimer's disease and related dementias. Work is performed in North Bethesda, Maryland. The order carries a firm fixed price and runs through July 31, 2029, comprising a 12-month base period beginning August 1, 2026, and two optional 12-month renewal...
- <p>The National Institute on Aging awarded a purchase order to Life Technologies Corporation for $7,995.00 on September 21, 2017, with completion targeted for October 21, 2017. Work is performed in Baltimore, Maryland. The order is firm fixed price with no small business set-aside. Specific scope details are not provided in the source.</p>
- The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $994,750 firm fixed price purchase order to Olink Proteomics AB of Isveç. The contract is for the delivery of Olink Explore 1536 Reagent Kits, or equal, to support laboratory testing needs at the National Institute on Aging in Baltimore, Maryland. The original solicitation sought these reagent kits to conduct relative protein quantitation using small sample volumes across multiple...
- <p>The National Institute on Aging awarded a purchase order to Olink Proteomics AB for $21,344.00 on September 15, 2017. Performance is located in Baltimore, Maryland. The order, which carries a firm fixed price, has an ultimate completion date of October 15, 2017. No set-aside category was used.</p>
- The Department of Health and Human Services' National Institutes of Health National Institute on Aging awarded Olink Proteomics Inc. a $74,130.04 firm fixed price purchase order to deliver EXPLORE 3072 REAGENT KITS. Performance will take place in Isveç, Turkey from July 25, 2023 through September 25, 2023. The National Institute on Aging supports biomedical research on the aging process and age-related diseases to promote the health and well-being of older adults. This purchase order for reagent...
- The National Institute on Aging (NIA) awarded a $97,757.34 firm fixed-price purchase order to Fujirebio US, Inc. to provide assay kits for the Lumipulse G1200 instrument. The purpose is to leverage existing data on neuroimaging, cognitive, and clinical factors to understand cognitive and brain changes in healthy individuals and those with comorbidities. The original sources sought notice indicated the government was looking to acquire state-of-the-art assay kits for quantification of...
The National Institute on Aging awarded a purchase order to Alamar Biosciences, Inc. for $99,990.00 on September 21, 2026, for NULISAseq Neuro 220 Panel multiplexed precision proteomics immunoassay panels and bulk reagents compatible with the ARGO HT System. Work is performed in Fremont, California, with delivery to the National Institute on Aging in Baltimore, Maryland within 30 days after receipt of order. The procurement requires quantity 7 of the NULISAseq Neuro 220 Panel—a 220-target biomarker panel detecting Abeta variants, phosphorylated tau variants, neurofilament light chain, and inflammatory and neurodegenerative disease markers at ultra-high sensitivity (as low as 0.1 fg/mL)—and quantity 2 of NULISA 10X Wash Buffer. The order is firm fixed price, carries no set-aside, and has an ultimate completion date of September 20, 2027. The originating solicitation was posted September 8, 2026, with proposals due September 14, 2026.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Multiplexed precision proteomics immunoassay panel for neurological disease biomarkers and bulk reagents | 75N98026Q01166 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Solicitation 1/1 | 9/8/26, 4:48 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $100.0k | 9/18/26 |